Keyphrases
Epilepsy
100%
Seizure
47%
Neuroinflammation
45%
Alzheimer's Disease
42%
High Mobility Group Box 1 (HMGB1)
34%
Zebrafish
32%
Zebrafish Model
30%
Traumatic Brain Injury
27%
Neurodegenerative Diseases
24%
Epileptogenesis
22%
Antiepileptic Drugs
20%
Pentylenetetrazole Kindling
19%
Embelin
19%
Neurotransmitters
18%
Cognitive Impairment
16%
Parkinson's Disease
16%
Kindling Model
16%
Anticonvulsive
16%
Anti-neuroinflammation
15%
Pentylenetetrazole
15%
Transgenic Zebrafish
15%
Epileptic Seizure
14%
Post-traumatic Epilepsy
14%
Epilepsy Treatment
14%
Seizure Models
14%
Neurological Disorders
13%
Molecular Mechanism
13%
Anticonvulsant
12%
Pathophysiology
12%
Narrative Review
11%
Epilepsy Model
11%
Acetylcholine
11%
Gut-brain Axis
11%
Gut Microbiota
11%
Inflammation
11%
Glutamate
10%
Translational Research
10%
Neurotoxicity
10%
Cognitive Dysfunction
10%
Molecular Crosstalk
10%
Channa Striata
9%
Neuroprotective Effect
9%
Naegleria Fowleri
9%
Primary Amoebic Meningoencephalitis
9%
Leaf Extract
9%
Glycyrrhizin
9%
Orthosiphon Stamineus
9%
PTZ-induced Seizure
9%
Tumor Necrosis Factor-α
9%
Neurodegeneration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
52%
Zebra Fish
52%
Nervous System Inflammation
50%
Disease
37%
Anticonvulsive Agent
33%
Epileptogenesis
26%
Neuroprotective Agent
26%
Biological Marker
24%
Inflammation
23%
Anti-Inflammatory Drug
20%
Pentetrazole
19%
Degenerative Disease
19%
Neurologic Disease
19%
Orthosiphon stamineus
19%
Comorbidity
17%
Traumatic Brain Injury
17%
Seizure
17%
Toll Like Receptor 4
17%
Embelin
14%
Tumor Necrosis Factor
14%
Blood-Brain Barrier
14%
Lipopolysaccharide
12%
Cognitive Defect
12%
Intestine Flora
12%
Antioxidant
12%
Neurotransmitter
11%
Receptor
10%
Melatonin
10%
Advanced Glycation End Product Receptor
9%
Channa striatus
9%
Pentylenetetrazole-Induced Seizure
9%
Nanoparticle
9%
Hydrogen Peroxide
9%
Primary Amebic Meningoencephalitis
9%
Naegleria fowleri
9%
Phospholipase A2
9%
Naja
9%
Polyphenol
9%
Glycyrrhizin
9%
Acute Toxicity
9%
Serotonin 2B Receptor
9%
Diabetic Ketoacidosis
9%
High Mobility Group B1 Protein
9%
Phytochemical
9%
Amyloid
9%
Sudden Death
9%
Nerve Degeneration
8%
Bioavailability
8%
Rat Model
8%
Ion Channel
8%
Medicine and Dentistry
Epileptic Seizure
45%
Systematic Review
35%
Alzheimer's Disease
21%
Gut Microbiota
21%
Gut
20%
Neuroinflammation
16%
Traumatic Brain Injury
15%
Toll Like Receptor 4
15%
Diseases
15%
Patient with Epilepsy
12%
Epileptogenesis
12%
Advanced Glycation End Product Receptor
11%
Dysbiosis
9%
Diabetic Ketoacidosis
9%
Hypokalemia
9%
Pentylenetetrazol
9%
Kindling Model
9%
Neurologic Disease
9%
Receptor
8%
Anticonvulsant
8%
Degenerative Disease
8%
Drug Therapy
7%
Quality of Life
6%
Cognitive Defect
6%
High Mobility Group B1 Protein
6%
Epilepsy
6%
Post-Traumatic Epilepsy
6%
Signal Transduction
6%
Blood Brain Barrier
5%
Butyric Acid
5%
Immunoreactivity
5%
Neurodegeneration
5%
Tau
5%
Symptom
5%
Brain Injury
5%